David Mountcastle Sells 7,697 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 7,697 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $25.05, for a total value of $192,809.85. Following the transaction, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at approximately $4,331,370.45. The trade was a 4.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

David Mountcastle also recently made the following trade(s):

• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $134,025.00.
• On Friday, December 12th, David Mountcastle sold 23,887 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $597,891.61.

Privia Health Group Stock Performance

Shares of PRVA opened at $23.77 on Wednesday. The stock has a market capitalization of $2.94 billion, a PE ratio of 139.82, a P/E/G ratio of 1.61 and a beta of 0.82. The company’s fifty day moving average is $23.07 and its 200 day moving average is $23.54. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The business had revenue of $541.17 million during the quarter, compared to analysts’ expectations of $516.61 million. During the same period last year, the company posted $0.21 EPS. The business’s revenue was up 17.4% on a year-over-year basis. As a group, research analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on PRVA. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research note on Monday, December 29th. Royal Bank Of Canada started coverage on Privia Health Group in a report on Friday, January 9th. They set an “outperform” rating and a $31.00 price target on the stock. Wolfe Research set a $31.00 price objective on shares of Privia Health Group in a research note on Tuesday, January 6th. Citigroup cut their price objective on shares of Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, Canaccord Genuity Group raised their target price on shares of Privia Health Group from $34.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, February 27th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $31.00.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Invesco Ltd. lifted its position in shares of Privia Health Group by 5.1% during the fourth quarter. Invesco Ltd. now owns 427,615 shares of the company’s stock worth $10,139,000 after purchasing an additional 20,652 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Privia Health Group by 3.8% during the 4th quarter. Wellington Management Group LLP now owns 233,446 shares of the company’s stock valued at $5,535,000 after buying an additional 8,531 shares in the last quarter. Millennium Management LLC lifted its holdings in Privia Health Group by 19.0% during the 4th quarter. Millennium Management LLC now owns 702,744 shares of the company’s stock valued at $16,662,000 after buying an additional 112,428 shares in the last quarter. Gotham Asset Management LLC boosted its position in Privia Health Group by 22.4% in the 4th quarter. Gotham Asset Management LLC now owns 36,995 shares of the company’s stock valued at $877,000 after buying an additional 6,773 shares during the period. Finally, Freestone Grove Partners LP grew its stake in Privia Health Group by 40.6% in the 4th quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock worth $28,768,000 after acquiring an additional 350,194 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Key Stories Impacting Privia Health Group

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Q4 results beat expectations — PRVA reported $0.25 EPS vs. $0.04 expected and revenue of $541.2M (up 17.4% YoY), a clear near‑term fundamental positive that supports higher valuations. Read More.
• Positive Sentiment: Truist raised its price target from $31 to $33 and kept a “buy” rating, which signals institutional confidence and can attract buyers. Read More.
• Positive Sentiment: Privia agreed to acquire Evolent’s ACO business to scale value‑based care — a strategic deal that could expand managed‑care revenue and improve margins if integration succeeds. Read More.
• Positive Sentiment: Privia‑led colorectal cancer screening program achieved an 84% screening rate, demonstrating execution in preventive care and EHR‑driven workflows — useful evidence for payor and provider partnerships. Read More.
• Neutral Sentiment: Citigroup trimmed its price target from $34 to $32 but maintained a “buy” rating — slightly dampening upside expectations while leaving the investment thesis intact. Read More.
• Negative Sentiment: Director Matthew Shawn Morris sold ~24,338 shares across Feb. 26–27 (~$608k), reducing his stake materially; heavy director sales can create short‑term selling pressure and hurt sentiment. Read More.
• Negative Sentiment: CFO David Mountcastle sold ~13,058 shares across Feb. 26–27 (~$327k); insider sales by senior finance executives are closely watched and may temper enthusiasm despite other positives. Read More.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.